The conference will focus on the 2016 healthcare industry outlook, disruptive innovation and venture philanthropy, non-dilutive financing, pricing and reimbursement, defining the value of drugs, innovation in drug discovery, personalized medicine, creative financing, emerging markets, innovative deal structures, and more.
The Boston Biotech Conferences (BBC)'s mission is to build a vibrant community of biopharma leaders, which will help to drive biopharma innovation in biotech, by convening leaders across industry and academia. The conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking, and corporate development within the biopharma community. For more information, visit: http://bbbiotechconference.com/conference-details.php?id=34
About SciClone
Forward-Looking Statements
This press release contains forward-looking statements regarding expected financial results and expectations. Readers are urged to consider statements that include the words 'may,' 'will,' 'would,' 'could,' 'should,' 'might,' 'believes,' 'estimates,' 'projects,' 'potential,' 'expects,' 'plans,' 'anticipates,' 'intends,' 'continues,' 'forecast,' 'designed,' 'goal,' 'unaudited,' 'approximately' or the negative of those words or other comparable words to be uncertain and forward-looking. These statements are subject to risks and uncertainties that are difficult to predict and actual outcomes may differ materially. Please also refer to other risks and uncertainties described in SciClone's filings with the
SciClone, SciClone Pharmaceuticals, the SciClone Pharmaceuticals design, the SciClone logo and ZADAXIN are registered trademarks of
Logo - http://photos.prnewswire.com/prnh/20150722/240358LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sciclone-to-present-at-boston-biotech-nynj-ceo-conference-on-november-12th-300170828.html
SOURCE
distributed by |